Steve Miller, Chief Op. & Scientific Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 50,000 shares at $21.93 ($1.1M) on 2024-12-10, disclosed to the SEC on 2024-12-11.
Seasonal sale ($1.1M) by Chief Op. & Scientific Officer — this insider has traded CPRX in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CPRX | SELL | 2023-12-07 | $570K | — | Filing → |
| CPRX | SELL | 2022-11-23 | $1.6M | — | Filing → |
| CPRX | SELL | 2022-09-15 | $2.4M | — | Filing → |